With this approval, Zydus has obtained 415 regulatory clearances and filed 483 Abbreviated New Drug Applications (ANDAs) as ...
Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback